Positive Regulatory Domain I-Binding Factor 1
                             
                            
                            
                                
                            
                            
                                
                            
                            
                            
                                
                                    
                                            
	"Positive Regulatory Domain I-Binding Factor 1" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, 
	MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, 
	which enables searching at various levels of specificity.
	
	
		
			
			
				A transcriptional repressor protein that contains an N-terminal PR-SET domain, four C-terminal CYS2-HIS2 ZINC FINGERS, and binds the PRDI element in the INTERFERON-BETA gene. It has methyltransferase activity and mediates gene transcription in tissue-specific innate and adaptive immune lymphocyte T-CELLS, repressing expression of proteins that promote exit of these tissue-specific T-cell populations from non-lymphoid organs.
    
			
			
				
				
					
						| Descriptor ID | 
										
							D000074462
						 | 			
					
					
						| MeSH Number(s) | 
						
							 D08.811.913.555.500.800.700 D12.776.260.703.650 D12.776.930.780.904 
						 | 
					
					
						| Concept/Terms | 
						
							Positive Regulatory Domain I-Binding Factor 1- Positive Regulatory Domain I-Binding Factor 1
 - Positive Regulatory Domain I Binding Factor 1
 - PRDI-BF1 Protein
 - PRDI BF1 Protein
 - B Lymphocyte-Induced Maturation Protein 1
 - B Lymphocyte Induced Maturation Protein 1
 - PRDM1 Protein
 - BLIMP1 Protein
 
  
						 | 
					
					
				
			 
			
				Below are MeSH descriptors whose meaning is more general than "Positive Regulatory Domain I-Binding Factor 1".
				
			 
			
			
				Below are MeSH descriptors whose meaning is more specific than "Positive Regulatory Domain I-Binding Factor 1".
				
			 
		 
	 
 
                                        
                                            
	
	
		
			
			
					
				This graph shows the total number of publications written about "Positive Regulatory Domain I-Binding Factor 1" by people in this website by year, and whether "Positive Regulatory Domain I-Binding Factor 1" was a major or minor topic of these publications. 
				
					
                    To see the data from this visualization as text, 
click here. 
				 
                
		            | Year | Major Topic | Minor Topic | Total | 
|---|
| 2004 | 0 | 1 | 1 | 
| 2005 | 0 | 2 | 2 | 
| 2006 | 0 | 1 | 1 | 
| 2011 | 0 | 1 | 1 | 
| 2012 | 0 | 1 | 1 | 
| 2013 | 0 | 2 | 2 | 
| 2017 | 0 | 1 | 1 | 
| 2019 | 0 | 1 | 1 | 
| 2025 | 0 | 1 | 1 | 
                    To return to the timeline, 
click here.
                 
			 	
			
			
			
			
				Below are the most recent publications written about "Positive Regulatory Domain I-Binding Factor 1" by people in Profiles.
						
					
								- 
								
Distinct plasmablast developmental intermediates produce graded expression of IgM secretory transcripts. Cell Rep. 2025 Feb 25; 44(2):115283.
															
								 
							
								- 
								
T-bet Transcription Factor Promotes Antibody-Secreting Cell Differentiation by Limiting the Inflammatory Effects of IFN-? on B Cells. Immunity. 2019 05 21; 50(5):1172-1187.e7.
															
								 
							
								- 
								
Dynamic regulation of T follicular regulatory cell responses by interleukin 2 during influenza infection. Nat Immunol. 2017 Nov; 18(11):1249-1260.
															
								 
							
								- 
								
Transcriptional regulation of germinal center B and plasma cell fates by dynamical control of IRF4. Immunity. 2013 May 23; 38(5):918-29.
															
								 
							
								- 
								
Nuclear protein dysregulation in lymphoplasmacytic lymphoma/waldenstrom macroglobulinemia. Am J Clin Pathol. 2013 Feb; 139(2):210-9.
															
								 
							
								- 
								
Molecular mechanisms that control the expression and activity of Bcl-6 in TH1 cells to regulate flexibility with a TFH-like gene profile. Nat Immunol. 2012 Mar 11; 13(4):405-11.
															
								 
							
								- 
								
Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin's lymphoma. Nat Med. 2011 Jul 24; 17(8):941-3.
															
								 
							
								- 
								
Graded expression of interferon regulatory factor-4 coordinates isotype switching with plasma cell differentiation. Immunity. 2006 Aug; 25(2):225-36.
															
								 
							
								- 
								
The zinc finger transcriptional repressor Blimp1/Prdm1 is dispensable for early axis formation but is required for specification of primordial germ cells in the mouse. Development. 2005 Mar; 132(6):1315-25.
															
								 
							
								- 
								
Blimp-1; immunoglobulin secretion and the switch to plasma cells. Curr Top Microbiol Immunol. 2005; 290:201-24.